Braxia Scientific to Discuss Psychiatric Treatment Discovery and Development with Oxford University Researchers at AIMday Experimental Medicine in Psychiatry on July 7, 2021

Braxia CEO Dr. Roger McIntyre will engage with Oxford scientists on the question of "How can we advance treatment discovery and development in psychiatry targeting cognition?"